Study: New DNA Vaccine Shuts Down Immune Cells that Cause Type 1 Diabetes
July 1, 2013 5:05 PM
comment(s) - last by
It leaves the rest of the immune system alone, though
Type 1 diabetes is a lifelong disease, but researchers at Stanford University are hoping to eliminate the effects of the disease -- and eventually cure it -- with a new vaccine.
Researchers from the Stanford School of Medicine -- led by Lawrence Steinman, MD, professor of pediatrics and of neurology and neurological sciences at Stanford -- have created a DNA vaccine that fights
type 1 diabetes
by targeting only a certain population of cells in the immune system without destroying the whole thing.
The vaccine consists of an altered piece of DNA, which holds the proinsulin gene. Beta cells, which are the only cells that make insulin in the body, start out as proinsulin precursor proteins. The beta cells, like all cells, display small pieces of the proteins they make on their surfaces called peptides, and the proinsulin peptides on the surface of beta cells cause misdirected CD8 cells (which are immune cells that patrol the cell surfaces for foreign peptides) to attack the beta cells.
The new DNA vaccine seeks out CD8 cells
targeting proinsulin; not all CD8 cells. If the vaccine had shut down the normal behavior of all CD8 cells, it would interfere with the patient's immune system and stop their bodies from being able to fight off infections and serious issues like cancer. Hence, shutting the whole system down isn't a better option.
That's why the vaccine only targets proinsulin-attacking CD8 cells and stops them from destroying beta cells while leaving everything else alone.
To test the vaccine, the research team recruited 80 type 1 diabetic patients that
required insulin therapy
. They divided the patients into five different groups, where four received different doses of the vaccine and one received a placebo.
Over the course of 12 weeks, the researchers measured levels of C-peptide in the patients, which is a piece of proinsulin that is cut off when insulin is pulled out of the proinsulin molecule. C-peptide is thought to fight off diabetic complications, such as eye and kidney damage.
The team checked the C-peptide levels before they began, then at five and 15 weeks, and then six, nine, 12, 18 and 24 months after starting on the vaccination. During these checks, blood was drawn 30, 60, 90 and 120 minutes after patients drank a modified milkshake.
According to results, levels of proinsulin-targeting CD8 cells were significantly depleted in patients who received the vaccine, compared with those getting placebo. However, other CD8 cells remained intact and left alone. Patients on the vaccine either had the same C-peptide levels or even increased levels, which would help them fight off diabetic complications later in life.
This article is over a month old, voting and posting comments is disabled
Not a cure....
7/2/2013 11:22:31 AM
I don't believe this is a "cure" in the traditional sense as in curing someone who already has the disease. A type I diabetic have lost all the beta cells which produce insulin as a result of the immune system attacking and killing the cells. I don't think this vaccine will result in the beta cells coming back/regenerating once they have been killed off.
What it can do, based on these initial studies, is block/prevent further deterioration/dead of beta cells in an individual in the early stages of the disease. This effectively will result in someone not becoming a type I diabetic by protecting the beta cells from being attacked by the immune system.
And if used as a general vaccine for the population (like the polio, chicken pox, MMR type vaccines) it could ultimately prevent formation of the disease in the population....thus curing/preventing the disease in the population.
"A lot of people pay zero for the cellphone ... That's what it's worth." -- Apple Chief Operating Officer Timothy Cook
Gene Therapy Controls, Cures Type 1 Diabetes in Dogs
February 11, 2013, 1:59 PM
Artificial Pancreas Improves Glucose Control by 15%, Benefits Type 1 Diabetes Patients
January 30, 2013, 5:55 PM
Former Android OS Chief Heading New Google Robotics Group
December 4, 2013, 1:20 PM
Dow Chemical to NYC City Council: You Don't Even Know What Styrofoam is!
December 2, 2013, 8:30 PM
Retired Israel Air Force Commander: UAVs Need to Dogfight Before Replacing Fighter Pilots
November 27, 2013, 3:59 PM
Eating High-Fat Diet During Puberty May Increase Speed of Breast Cancer Development
November 27, 2013, 2:15 PM
Mayor Bloomberg Says No More Polystyrene Foam Dishes in NYC, Says it Can Cause Cancer
November 25, 2013, 11:51 AM
NASA Rejects Billionaire's Mission to Mars
November 22, 2013, 12:31 PM
Most Popular Articles
NSA Snares Americans' Porn Viewing Histories in Effort to Target Muslims
December 1, 2013, 9:00 PM
Coalition of 20+ Tech Firms Backs MRAM as Potential DRAM, NAND Replacement
November 29, 2013, 11:59 PM
Fed Up With Cheating OEMs, Microsoft Trolls Chromebooks in New Ad
November 27, 2013, 4:09 PM
Xbox? PCs? Mobile? Microsoft Wants One Windows to Rule Them All
November 25, 2013, 8:21 PM
Seattle Restaurant Bans Google Glass, Tells Wearers to "Just shut up and get out"
November 27, 2013, 10:27 AM
Latest Blog Posts
Global Cyber Espionage Concerns Reveal Growing Cyber Armies
Nov 29, 2013, 11:04 AM
Is The Period Becoming an Expression of Anger?
Nov 26, 2013, 2:02 PM
NSA and Congress -- You Will Never Kill the Constitution, It's an Idea
Nov 10, 2013, 2:00 PM
AT&T Explores $100B+ USD Deal to Acquire Vodafone's European Operations
Nov 4, 2013, 7:34 AM
U.S. Army Developing Cyber, Electronic War Arsenal
Oct 31, 2013, 4:49 PM
More Blog Posts
Copyright 2013 DailyTech LLC. -
Terms, Conditions & Privacy Information